Omega Healthcare Investors Stock Forecast, Price & News

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Omega Healthcare Investors in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Omega Healthcare Investors stock.
View analyst ratings for Omega Healthcare Investors or view top-rated stocks.

Wall Street analysts have given Omega Healthcare Investors a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Omega Healthcare Investors wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Omega Healthcare Investors saw a increase in short interest during the month of May. As of May 28th, there was short interest totaling 9,460,000 shares, an increase of 22.5% from the May 13th total of 7,720,000 shares. Based on an average daily volume of 2,020,000 shares, the days-to-cover ratio is presently 4.7 days. Currently, 4.0% of the company's stock are short sold.
View Omega Healthcare Investors' Short Interest.

Omega Healthcare Investors is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Omega Healthcare Investors.

Omega Healthcare Investors, Inc. (NYSE:OHI) posted its quarterly earnings results on Sunday, May, 2nd. The real estate investment trust reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.24. The real estate investment trust had revenue of $234.83 million for the quarter, compared to analyst estimates of $225.64 million. Omega Healthcare Investors had a trailing twelve-month return on equity of 5.63% and a net margin of 25.12%. The company's revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.79 earnings per share.
View Omega Healthcare Investors' earnings history.

Omega Healthcare Investors' stock was trading at $31.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OHI shares have increased by 14.0% and is now trading at $35.85.
View which stocks have been most impacted by COVID-19.

Omega Healthcare Investors announced a quarterly dividend on Friday, April 23rd. Shareholders of record on Monday, May 3rd will be given a dividend of $0.67 per share on Monday, May 17th. This represents a $2.68 annualized dividend and a dividend yield of 7.48%. The ex-dividend date is Friday, April 30th.
View Omega Healthcare Investors' dividend history.

Omega Healthcare Investors pays an annual dividend of $2.68 per share and currently has a dividend yield of 7.48%. OHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Omega Healthcare Investors does not yet have a strong track record of dividend growth. The dividend payout ratio of Omega Healthcare Investors is 82.97%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Omega Healthcare Investors will have a dividend payout ratio of 79.76% in the coming year. This indicates that Omega Healthcare Investors may not be able to sustain their current dividend.
View Omega Healthcare Investors' dividend history.

10 brokerages have issued 12-month target prices for Omega Healthcare Investors' shares. Their forecasts range from $30.00 to $43.00. On average, they expect Omega Healthcare Investors' stock price to reach $37.46 in the next twelve months. This suggests a possible upside of 4.5% from the stock's current price.
View analysts' price targets for Omega Healthcare Investors or view top-rated stocks among Wall Street analysts.

3 employees have rated Omega Healthcare Investors CEO C. Taylor Pickett on Glassdoor.com. C. Taylor Pickett has an approval rating of 56% among Omega Healthcare Investors' employees. This puts C. Taylor Pickett in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Omega Healthcare Investors include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Extra Space Storage (EXR), Ventas (VTR), Medical Properties Trust (MPW), CubeSmart (CUBE), Life Storage (LSI), Rayonier (RYN), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), EPR Properties (EPR), Sabra Health Care REIT (SBRA) and PotlatchDeltic (PCH).
View all of OHI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Omega Healthcare Investors investors own include AT&T (T), Enterprise Products Partners (EPD), Verizon Communications (VZ), Energy Transfer (ET), Realty Income (O), Cisco Systems (CSCO), AbbVie (ABBV), Annaly Capital Management (NLY), New Residential Investment (NRZ) and Pfizer (PFE).

Omega Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "OHI."

Omega Healthcare Investors' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.22%), Bank of New York Mellon Corp (1.89%), Geode Capital Management LLC (1.64%), Dimensional Fund Advisors LP (1.41%), Northern Trust Corp (1.37%) and Amundi Asset Management US Inc. (1.35%). Company insiders that own Omega Healthcare Investors stock include Burke W Whitman, C Taylor Pickett, Craig R Callen, Daniel J Booth, Michael Ritz, Robert O Stephenson and Steven J Insoft.
View institutional ownership trends for Omega Healthcare Investors.

OHI stock was sold by a variety of institutional investors in the last quarter, including Daiwa Securities Group Inc., Mirae Asset Global Investments Co. Ltd., Goldman Sachs Group Inc., LSV Asset Management, Morgan Stanley, Sei Investments Co., Bank of New York Mellon Corp, and NN Investment Partners Holdings N.V.. Company insiders that have sold Omega Healthcare Investors company stock in the last year include C Taylor Pickett, Daniel J Booth, and Robert O Stephenson.
View insider buying and selling activity for Omega Healthcare Investors or view top insider-selling stocks.

OHI stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Massachusetts Financial Services Co. MA, D. E. Shaw & Co. Inc., Amundi Asset Management US Inc., Prudential Financial Inc., Avalon Investment & Advisory, Geode Capital Management LLC, and Jupiter Asset Management Ltd.. Company insiders that have bought Omega Healthcare Investors stock in the last two years include Burke W Whitman, and Craig R Callen.
View insider buying and selling activity for Omega Healthcare Investors or or view top insider-buying stocks.

Shares of OHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OHI stock can currently be purchased for approximately $35.85.

Omega Healthcare Investors has a market capitalization of $8.44 billion and generates $892.38 million in revenue each year. The real estate investment trust earns $159.33 million in net income (profit) each year or $3.23 on an earnings per share basis.

Omega Healthcare Investors employs 68 workers across the globe.

The official website for Omega Healthcare Investors is www.omegahealthcare.com.

Omega Healthcare Investors is headquartered at 303 International Circle Suite 200, HUNT VALLEY MD, 21030.

Omega Healthcare Investors' mailing address is 303 International Circle Suite 200, HUNT VALLEY MD, 21030. The real estate investment trust can be reached via phone at 410-427-1700 or via email at [email protected]